used in traditional Chinese, Ayurvedic, and Thai drugs. Conolidine could stand for the start of a different era of Serious pain management. It is currently being investigated for its outcomes within the atypical chemokine receptor (ACK3). In a rat product, it had been uncovered that a competitor molecule binding to ACKR3 resulted in inhibition of A